agree masada , comments such as those below from the annual report reflect the positive outlook for the MAS product. also top 20 has seen quite a few changes, most notably the myer family accumulating 15.7m shares in the last 12months.
"At the same time we are aware of a number of clinical research projects, which are taking place in several countries, managed and supervised by outstanding scientists and practitioners from many different universities all exploring and confirming the efficacy and benefit of MAS in the treatment of obstructive sleep apnea, often in direct comparison with CPAP. Theresults are most encouraging for all parties involved and point to a great future for MAS, our SomnoDent™ products and Somnomed Limited"
http://www.somnomed.com.au/annual-reports/Somnomed-Annual-Report-2008.pdf
positive results for som, page-2
Add SOM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
35.0¢ |
Change
0.005(1.45%) |
Mkt cap ! $75.63M | |||
| Open | High | Low | Value | Volume |
| 34.5¢ | 35.0¢ | 34.5¢ | $19.79K | 57.24K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30000 | 32.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 35.0¢ | 4005 | 2 |
View Market Depth
| Last trade - 16.10pm 16/07/2024 (20 minute delay) ? |
| SOM (ASX) Chart |